{"id":"https://openalex.org/W2402215951","doi":null,"title":"[Molecular predictive markers of EGFR-targeted therapy in metastatic colorectal cancer].","display_name":"[Molecular predictive markers of EGFR-targeted therapy in metastatic colorectal cancer].","alternate_titles":[],"publication_year":2011,"publication_date":"2011-10-01","ids":{"openalex":"https://openalex.org/W2402215951","mag":"2402215951","pmid":"https://pubmed.ncbi.nlm.nih.gov/22145213"},"language":"cs","primary_location":{"id":"pmid:22145213","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22145213","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ceskoslovenska patologie","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2402215951"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080594950","display_name":"Pavel Fabi\u00e1n","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P Fabian","raw_affiliation_strings":["Oddelen\u00ed onkologick\u00e9 a experiment\u00e1ln\u00ed patologie, Masaryk\u016fv onkologick\u00fd, \u00fastav, Brno. fabian@mou.cz","Oddelen\u00ed onkologick\u00e9 a experiment\u00e1ln\u00ed patologie, Masaryk\u016fv onkologick\u00fd, \u00fastav, Brno"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oddelen\u00ed onkologick\u00e9 a experiment\u00e1ln\u00ed patologie, Masaryk\u016fv onkologick\u00fd, \u00fastav, Brno. fabian@mou.cz","institution_ids":[]},{"raw_affiliation_string":"Oddelen\u00ed onkologick\u00e9 a experiment\u00e1ln\u00ed patologie, Masaryk\u016fv onkologick\u00fd, \u00fastav, Brno","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012142431","display_name":"Jitka Berkovcov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J Berkovcov\u00e1","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1505,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.53169734,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"47","issue":"4","first_page":"154","last_page":"158"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-egfr-therapy","display_name":"anti-EGFR therapy","score":0.9110000133514404},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9509999752044678},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.9990000128746033},{"id":"https://openalex.org/keywords/panitumumab","display_name":"panitumumab","score":0.9319999814033508},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":1.0},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.9539999961853027},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.996999979019165},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.9919999837875366},{"id":"https://openalex.org/keywords/pten-loss","display_name":"PTEN loss","score":0.9679999947547913},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.7329999804496765},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.6060000061988831}],"concepts":[{"id":"https://openalex.org/C2778332735","wikidata":"https://www.wikidata.org/wiki/Q417775","display_name":"Panitumumab","level":5,"score":0.9676064252853394},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.927100419998169},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.9143142700195312},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.7425559163093567},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7379082441329956},{"id":"https://openalex.org/C2780521871","wikidata":"https://www.wikidata.org/wiki/Q7239671","display_name":"Predictive marker","level":3,"score":0.6450235843658447},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6025497317314148},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.5790441036224365},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5276735424995422},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4972284138202667},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4879853129386902},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48145025968551636},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.44731929898262024},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38878005743026733},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20217189192771912},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.17065104842185974},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.09342730045318604},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077544","descriptor_name":"Panitumumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D016283","descriptor_name":"Proto-Oncogene Proteins p21(ras)","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018631","descriptor_name":"ras Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051059","descriptor_name":"PTEN Phosphohydrolase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D058534","descriptor_name":"Class I Phosphatidylinositol 3-Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:22145213","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22145213","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ceskoslovenska patologie","raw_type":"Journal Article"},{"id":"mag:2402215951","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22145213","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2108468456","https://openalex.org/W1975493557","https://openalex.org/W4246981307","https://openalex.org/W2004934664","https://openalex.org/W2098462873","https://openalex.org/W2312302108","https://openalex.org/W4318274231","https://openalex.org/W2259017904","https://openalex.org/W2138970634","https://openalex.org/W2093367899"],"abstract_inverted_index":{"The":[0,37],"monoclonal":[1,157],"antibodies":[2],"panitumumab":[3,124,197],"and":[4,18,31,126,196],"cetuximab":[5,122,195],"that":[6,39,183],"target":[7],"the":[8,70,84,92,155,161,194],"epidermal":[9],"growth":[10],"factor":[11],"receptor":[12],"are":[13,178],"effective":[14],"in":[15,29,32,49,104,131,168,204],"approximately":[16],"10%":[17],"20%":[19],"of":[20,65,69,75,83,94,106,119,140,146],"EGFR":[21,40,50,164],"expressing,":[22],"chemotherapy":[23],"resistant":[24],"metastatic":[25],"colorectal":[26,95,109],"cancer":[27],"patients":[28,107],"monotherapy":[30],"combination":[33],"with":[34,108,152],"chemotherapy,":[35],"respectively.":[36],"evidence":[38],"expression":[41,148,185],"by":[42],"immunohistochemistry":[43],"does":[44],"not":[45],"predict":[46],"clinical":[47,132,191,206,211],"outcome":[48],"targeted":[51],"treatment":[52,125],"has":[53],"led":[54],"to":[55,91,121,154,190],"an":[56,115],"intensive":[57],"search":[58],"for":[59],"additional":[60],"predicitive":[61],"biomarkers.":[62],"Oncogenic":[63],"activation":[64],"signalling":[66],"pathways":[67],"downstream":[68],"EGFR,":[71],"such":[72],"as":[73,114],"mutation":[74],"KRAS,":[76,138],"BRAF,":[77],"or":[78,81,123,142,144],"PIK3CA":[79,143],"oncogenes,":[80],"inactivation":[82],"PTEN":[85,147],"tumor":[86,169],"supressor":[87],"gene":[88,184],"is":[89,111,127,171],"central":[90],"progression":[93],"cancer.":[96],"Tumor":[97],"KRAS":[98],"mutation,":[99],"which":[100],"may":[101,149],"be":[102,150],"present":[103],"35%-45%":[105],"cancer,":[110],"now":[112],"recognized":[113],"important":[116],"predictive":[117,175],"marker":[118],"resistance":[120,153],"also":[128,179,188],"widely":[129],"used":[130],"practice.":[133,212],"Among":[134],"tumors":[135],"carrying":[136],"wild-type":[137],"mutations":[139],"BRAF":[141],"loss":[145],"associated":[151],"anti-EGFR":[156],"antibody":[158],"treatment.":[159],"On":[160],"other":[162],"hand,":[163],"ligands":[165],"overexpression":[166],"detected":[167],"tissue":[170],"a":[172],"promising":[173],"positive":[174],"marker.":[176],"There":[177],"some":[180],"initial":[181],"observations":[182,200],"profiling":[186],"could":[187],"contribute":[189],"decision-making":[192],"about":[193],"treatments.":[198],"These":[199],"require":[201],"further":[202],"validation":[203],"prospective":[205],"trials":[207],"before":[208],"incorporation":[209],"into":[210]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2402215951","counts_by_year":[{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
